Cargando…

Baseline nutritional status could be a predictor for radiation esophagitis in esophageal cancer patients undergoing radiotherapy

BACKGROUND: To investigate the relationship between baseline nutrition status and radiation esophagitis in patients with esophageal cancer treated by radiation therapy. METHODS: A retrospective study was performed on 100 patients with esophageal cancer who was treated with definitive chemoradiothera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Jie, Zhang, Wencheng, Zhang, Tian, Chen, Xi, Zhao, Jingjing, Zeng, Yaqi, Chen, Yajun, Wei, Xiaoying, Lei, Tongda, Wang, Ping, Zhao, Lujun, Wang, Jun, Yuan, Zhiyong, Song, Yongchun, Liu, Ningbo, Wang, Kun, Pang, Qingsong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576065/ https://www.ncbi.nlm.nih.gov/pubmed/33240997 http://dx.doi.org/10.21037/atm-20-4078

Ejemplares similares

Platelet-to-lymphocyte ratio is an independent predictor of chemoradiotherapy-related esophageal fistula in esophageal cancer patients
por: Han, Dong, et al.
Publicado: (2020)

Annual report of the esophageal cancer radiation group of the Department of Radiotherapy, Tianjin Medical University Cancer Institute & Hospital
por: Pang, Qingsong, et al.
Publicado: (2020)

The efficacy and safety of simultaneous integrated dose reduction in clinical target volume with intensity-modulated radiotherapy for patients with locally advanced esophageal squamous cell carcinoma
por: Zhao, Jingjing, et al.
Publicado: (2020)

Predictive value of EGF and uPAR for chemoradiotherapy response and survival in patients with esophageal squamous cell carcinoma
por: Chen, Xi, et al.
Publicado: (2020)

Clinical results of intensity-modulated radiotherapy for 250 patients with cervical and upper thoracic esophageal carcinoma
por: Zhang, Jiaqi, et al.
Publicado: (2019)

Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2021)

Prognostic value of supraclavicular nodes and upper abdominal nodes metastasis after definitive chemoradiotherapy for patients with thoracic esophageal squamous cell carcinoma
por: Li, Xue, et al.
Publicado: (2017)

The expression of PDGF-BB predicts curative effect in locally advanced esophageal squamous cell carcinoma treated by radiotherapy
por: Er, Puchun, et al.
Publicado: (2020)

Spatial Distribution and Predictive Significance of Dendritic Cells and Macrophages in Esophageal Cancer Treated With Combined Chemoradiotherapy and PD-1 Blockade
por: Ma, Xiaoxue, et al.
Publicado: (2022)

XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma
por: Cheng, Jingjing, et al.
Publicado: (2015)

Immune checkpoint inhibitors for esophageal squamous cell carcinoma: a narrative review
por: Zhang, Wencheng, et al.
Publicado: (2020)

Addition of camrelizumab to docetaxel, cisplatin, and radiation therapy in patients with locally advanced esophageal squamous cell carcinoma: a phase 1b study
por: Zhang, Wencheng, et al.
Publicado: (2021)

Immunotherapy with or without radiotherapy for metastatic or recurrent esophageal squamous cell carcinoma: A real-world study
por: Wu, Xiaoyue, et al.
Publicado: (2022)

NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc
por: Wang, Yuwen, et al.
Publicado: (2018)

Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockade
por: Yan, Cihui, et al.
Publicado: (2022)

Efficacy and safety of weekly nab-paclitaxel plus cisplatin with concurrent intensity-modulated radiotherapy in patients with inoperable, locally advanced esophageal cancer: a pilot trial
por: Wang, Daquan, et al.
Publicado: (2018)

A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis
por: Li, Yang, et al.
Publicado: (2021)

Nomograms for predicting progression and efficacy of post-operation radiotherapy in IIIA-pN2 non-small cell lung cancer patients
por: Zhang, Baozhong, et al.
Publicado: (2017)

The influence of the metastasis pattern of mediastinal lymph nodes on the postoperative radiotherapy’s efficacy for the IIIA-pN2 non-small-cell lung cancer: a retrospective analysis of 220 patients
por: Zhang, Baozhong, et al.
Publicado: (2016)

Concurrent or Sequential Chemoradiotherapy after 3-4 Cycles Induction Chemotherapy for LS-SCLC with Bulky Tumor
por: Zhao, Jingjing, et al.
Publicado: (2020)

Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma
por: Du, Qingwu, et al.
Publicado: (2023)

Induction of PD-L1 expression by epidermal growth factor receptor–mediated signaling in esophageal squamous cell carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2017)

Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma
por: Zhuang, Hongqing, et al.
Publicado: (2013)

Correction: Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma
por: Du, Qingwu, et al.
Publicado: (2023)

Combination of 35-Gene Mutation Profile and Radiotherapy Dosimetry Predicts the Therapeutic Outcome of Definitive Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma
por: Tang, Peng, et al.
Publicado: (2021)

Dose escalation of 3D radiotherapy is effective for esophageal squamous cell carcinoma: a multicenter retrospective analysis (3JECROG R-03)
por: Zhang, Wencheng, et al.
Publicado: (2020)

Programmed death‐ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor
por: Zhang, Wencheng, et al.
Publicado: (2017)

Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy
por: Zhuang, Hongqing, et al.
Publicado: (2014)

Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
por: Luo, Jing, et al.
Publicado: (2017)

Efficacy of intensity-modulated radiotherapy for resected thoracic esophageal squamous cell carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2015)

Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer
por: Zhao, Lina, et al.
Publicado: (2017)

Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy
por: Yuan, Shuanghu Tiger, et al.
Publicado: (2014)

Prognostic values of the gross volume of metastatic lymph nodes in patients with esophageal squamous cell carcinoma treated with definitive concurrent chemoradiotherapy
por: Li, Yang, et al.
Publicado: (2022)

Stage III Esophageal Squamous Cell Carcinoma Patients With Three-Dimensional Conformal or Intensity-Modulated Radiotherapy: A Multicenter Retrospective Study
por: Qin, Qin, et al.
Publicado: (2020)

Role of clip markers placed by endoscopic ultrasonography in contouring gross tumor volume for thoracic esophageal squamous cell carcinoma: one prospective study
por: Guan, Yong, et al.
Publicado: (2020)

Chemoradiotherapy-Induced CD4(+) and CD8(+) T-Cell Alterations to Predict Patient Outcomes in Esophageal Squamous Cell Carcinoma
por: Chen, Xi, et al.
Publicado: (2019)

Risk factors of esophageal fistula induced by re-radiotherapy for recurrent esophageal cancer with local primary site
por: Wang, Xinran, et al.
Publicado: (2022)

Risk Factors Associated with Esophageal Fistula after Radiotherapy for Esophageal Squamous Cell Carcinoma
por: Hu, Bing, et al.
Publicado: (2020)

Esophageal perforation during or after conformal radiotherapy for esophageal carcinoma
por: Chen, Hai-yan, et al.
Publicado: (2014)

Radiotherapy Alone or Concurrent Chemoradiation for Esophageal Squamous Cell Carcinoma in Elderly Patients
por: Zhao, Lina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sg4kpi8l6kplelsp8prm387r0l